Clinical trial
Intravenous Infusions of S-KETAMINE in Fibromyalgia Syndromes: an Exploratory Study.
NCT04436250 is registered in ClinicalTrials.gov with Grand Hôpital de Charleroi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intravenous Infusions of S-KETAMINE in Fibromyalgia Syndromes: an Exploratory Study.
- Lead sponsor
- Grand Hôpital de Charleroi
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- October 10, 2020
- Completion date
- September 30, 2024
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.